» Articles » PMID: 29896480

Use of Antihypertensive Drugs During Preeclampsia

Overview
Date 2018 Jun 14
PMID 29896480
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Treatment of pregnancy-related hypertensive disorders, such as preeclampsia (PE), remain a challenging problem in obstetrics. Typically, aggressive antihypertensive drug treatment options are avoided to prevent pharmacological-induced hypotension. Another major concern of administering antihypertensive drugs during pregnancy is possible adverse fetal outcome. In addition, management of hypertension during pregnancy in chronic hypertensive patients or in patients with prior kidney problems are carefully considered. Recent studies suggest that PE patients are at increased cardiovascular risk postpartum. Therefore, these patients need to be monitored postpartum for the subsequent development of other cardiovascular diseases. In this review article, we review the antihypertensive drugs currently being used to treat patients with PE and the advantages or disadvantages of using these drugs during pregnancy.

Citing Articles

Circulating microRNAs in Body Fluid: "Fingerprint" RNA Snippets Deeply Impact Reproductive Biology.

Mukherjee A, Verma A, Das T, Ghosh B, Ghosh Z Reprod Sci. 2024; 32(3):555-574.

PMID: 39658771 DOI: 10.1007/s43032-024-01753-y.


Diagnosis and Treatment of Eclampsia.

Katsi V, Svigkou A, Dima I, Tsioufis K J Cardiovasc Dev Dis. 2024; 11(9).

PMID: 39330315 PMC: 11432638. DOI: 10.3390/jcdd11090257.


The Roles of Obesity and ASB4 in Preeclampsia Pathogenesis.

Wang Y, Ssengonzi R, Townley-Tilson W, Kayashima Y, Maeda-Smithies N, Li F Int J Mol Sci. 2024; 25(16).

PMID: 39201703 PMC: 11354233. DOI: 10.3390/ijms25169017.


Importance of the (Pro)renin Receptor in Activating the Renin-Angiotensin System During Normotensive and Preeclamptic Pregnancies.

Schofield L, Endacott S, Delforce S, Lumbers E, Pringle K Curr Hypertens Rep. 2024; 26(12):483-495.

PMID: 39093387 PMC: 11455731. DOI: 10.1007/s11906-024-01316-1.


Advancing hypertensive disorders of pregnancy management: insights from the 5th preeclampsia scientific symposium in Ghana.

Koi-Larbi K, Obiri D, Browne J, Fondjo L, Katsande S, Garti I BMC Proc. 2024; 18(Suppl 10):12.

PMID: 38867245 PMC: 11170767. DOI: 10.1186/s12919-024-00295-0.


References
1.
Duley L, Henderson-Smart D . Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev. 2003; (4):CD000128. DOI: 10.1002/14651858.CD000128. View

2.
Duley L, Henderson-Smart D . Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev. 2003; (4):CD000127. DOI: 10.1002/14651858.CD000127. View

3.
Rezaei Z, Sharbaf F, Pourmojieb M, Youefzadeh-Fard Y, Motevalian M, Khazaeipour Z . Comparison of the efficacy of nifedipine and hydralazine in hypertensive crisis in pregnancy. Acta Med Iran. 2011; 49(11):701-6. View

4.
Lain K, Roberts J . Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA. 2002; 287(24):3183-6. DOI: 10.1001/jama.287.24.3183. View

5.
Cunningham F, Lindheimer M . Hypertension in pregnancy. N Engl J Med. 1992; 326(14):927-32. DOI: 10.1056/NEJM199204023261405. View